3 Stocks To Watch From Wells Fargo’s New “Signature Picks” List

Tuesday, May 4, 2021 | Sam Quirke
3 Stocks To Watch From Wells Fargo’s New “Signature Picks” List

3 Stocks To Watch From Wells Fargo’s New “Signature Picks” List

The start of a new month is never a bad time to revisit your portfolio and see if there are any changes to be made. With the major indices currently trading around all-time highs, there’s definitely a prevailing risk-on sentiment in equity markets, even as many of the tech titans that led last year’s rally take an extended breather. 

It looks like the folks over at Wells Fargo share this feeling, as they published what’s being called their “Signature Picks” list yesterday. It’s a portfolio of 35 stocks, with an average expected return of 15%, and with a general focus on those with existing momentum. There were four criteria for inclusion; an attractive risk/reward profile over the coming year, existing ratings of Overweight and High Conviction by Wells Fargo’s analysts, they must pass a peer review by the list’s committee, and they must have a six-month average daily trading volume of at least $5 million. 

In a note to clients, they introduced it as a portfolio that will “be more risky and more aggressively positioned than our former QQP model portfolio, which concentrated on defense first and offense second. However, Signature Picks on occasion will take a more risk-averse stance based on internal metrics and fundamental stock outlooks." With that in mind, let’s take a closer look at 3 stocks from the list that look particularly appetizing at current prices. 

Norfolk Southern Railway (NYSE:NSC)

Shares of NSC have barely taken a breather since their current rally started around this time last year. Whereas most of last year’s leaders saw some heavy selling this past February, NSC went into that month close to an all time high and left it close to an even higher all time high. Since then they’ve continued their march northwards and are up about 90% in the past twelve months. 

Their Q1 report last week showed a revenue engine that’s ticking over nicely, as the company set a quarterly record for its EPS, its income, and its operating ratio. According to Wells Fargo, investors can expect more of the same and the $315 price target that’s been slapped onto them suggests upside of more than 10% from Monday’s closing price. 

Johnson & Johnson (NYSE:JNJ)

JNJ will be a familiar ticker to many investors at this point, due in large part to their COVID vaccine being used as part of the global rollout. Having recovered all of the ground lost to the COVID led crash within a month last year, shares traded largely sideways until late November. But since then they’ve been ticking upwards and Wells Fargo sees this trend continuing. 

For a $400 billion pharma behemoth, JNJ is well able to outperform expectations and last month’s earnings report comfortably beat those of the analysts on both the topline and bottom-line numbers. The same report also showed management increasing their full year guidance, an uber-bullish signal that surely played a part in their inclusion on this list. 

Bank of America (NYSE:BAC)

With a 130% rally notched since March of last year, shares of BAC are without a doubt among the best performing of the big banks right now. The higher rate environment that we’re starting to see evolve is doing them no harm at all, with the stock up 40% in the past three months alone. 

For those of us on the sidelines, however, there’s every reason to expect the rally to continue and there’s plenty of room still onboard. Wells Fargo sees shares hitting $48 this year, which suggests an upside of at least another 20% from current levels, and it’s hard to see that number not being hit with the current pace. 

A comfortable beat on analyst expectations in April’s Q1 earnings ticked the box for most of Wall Street, while a juicy dividend yield of 1.8% should keep most impatient investors happy while the rally plays out, and BAC shares continue setting decade highs.

Featured Article: What is FinTech?



7 Penny Stocks That Don’t Care About Robinhood

By the time you read this Vladimir Tenev, the CEO of the trading app Robinhood, will be testifying in front of Congress. The company’s role in the GameStop (NYSE:GME) short squeeze will be called into question.

However, the real issue at stake is the right of traders to buy and sell the equities of their choice. In the case of Robinhood, some traders are buying a lot of penny stocks. While definitions vary, penny stocks are generally considered stocks that are trading for less than $10 per share. These stocks are largely ignored by the investment community.

One reason is that many of these stocks are cheap for a reason. For example, the company may have a business model that is out of date. In other cases, they operate in a very small, niche market that doesn’t drive a lot of revenue.

And most of these stocks are ignored by the investment community. They simply aren’t considered significant enough to spend time debating.

But some penny stocks do have the attention of Wall Street. And they’re being largely ignored by the day trading community. The focus of this special presentation is to direct you to penny stocks that have a story that the “smart money” thinks will eventually be trading at much higher prices.

And that’s why you should be looking at them now.

View the "7 Penny Stocks That Don’t Care About Robinhood".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Bank of America (BAC)2.4$42.01+1.5%1.71%20.80Buy$37.84
Johnson & Johnson (JNJ)2.5$167.74+0.4%2.41%26.37Buy$185.70
Norfolk Southern (NSC)1.9$286.97+0.3%1.38%36.93Buy$262.75
Compare These Stocks  Add These Stocks to My Watchlist 

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at c[email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.